Announcement on Holding Investor Reception Day 2025
Filed with SSE · · 5 pages · Chinese
Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Earlier from Zhejiang Shouxiangu Pharmaceutical
- Report for Q1 2025
- 2024 Annual Preliminary Earnings Estimate
- Announcement on Completion of Filing of Domestic Health Food by Wholly-owned Subsidiary
- Announcement on Using Partial Idle Raised Funds for Cash Management and Early Redemption
- Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
Later from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Election of Employee Representative Supervisor for the 5th Board of Supervisors
- Announcement on Equity Change of Actual Controller and Persons Acting in Concert Reaching 5% Scale and Progress of Share Increase Plan
- Announcement on Resolution of the 1st Meeting of the 5th Board of Supervisors
- Announcement on Progress in Equity Acquisition and Related Party Transactions
- Indicative Announcement on Stopping the Conversion of "Shou22 Convertible Bonds" during Implementation of Dividend Distribution
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical